<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/27CC2B52-35C5-4091-95EB-F3FFDBA95387"><gtr:id>27CC2B52-35C5-4091-95EB-F3FFDBA95387</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>Simon</gtr:otherNames><gtr:surname>Ware</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_1102%2F20"><gtr:id>C0F94A37-BA22-4F00-8B33-40A6384A4300</gtr:id><gtr:title>Cardiovascular Genetics and Genomics</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_1102/20</gtr:grantReference><gtr:abstractText>Our aims are to understand the how inherited (genetic) factors influence the heart and circulation, and to use genetic information to improve patient care. 

Gene discovery in rare heart diseases ? we are using state-of-the-art approaches to find genes that cause rare heart diseases that run in families, particularly severe heart muscle diseases in children. As well as providing answers for the families affected, we also hope to find new treatments for these conditions.

Gene interpretation ? having found genes that are linked to a disease, we need to understand precisely what changes in those genes cause problems. We all have some genetic changes that are unique to us, and most of these do not cause any problems. We are trying to find ways of distinguishing between those genetic changes that cause disease, and those that do not.

Precision medicine ? for any particular disease, there is seldom a single best treatment that works for everybody. Tailoring treatments to individual patients is a high priority, as it leads to better outcomes and saves money (that is wasted if people receive ineffective treatment). We are finding genetic markers that predict which patients with heart muscle diseases need specific therapies.</gtr:abstractText><gtr:technicalSummary>The group?s overarching research aims are to understand the impact of genetic variation on the heart and circulation, and to use genome information to improve patient care. Several research themes contribute to these aims:

Gene discovery in rare cardiovascular disease ? we are using exome and genome sequencing approaches in humans to find genes that cause rare Mendelian disease, particularly severe childhood cardiomyopathies (heart muscle diseases), both to provide answers to the families affected, and also to find new therapeutic targets for the treatment of these conditions. Having identified candidate disease genes through sequencing in humans, we are using genome engineering in stem-cell derived cardiomyocytes to further characterise the role of these genes in the heart, to determine mechanisms of pathogenicity, and to identify targets for therapeutic modulation.

Variant interpretation ? all of us carry rare variants that alter important genes. Distinguishing between those that cause disease and those that are innocent bystanders is a key challenge in contemporary clinical genetics. We are developing and applying new methods to address this challenge, and collaborating globally to refine our understanding of variation in genes associated with heart disease. We are aggregating large cohorts of subjects with inherited cardiac conditions (mainly cardiomyopathies) and reference samples both locally and through collaboration (e.g. the NIHR Royal Brompton Cardiovascular BRU BioBank, the Exome Aggregation Consortium, the Clinical Genome Resource, Genomics England, Oxford Molecular Genetics Laboratory, Laboratory for Molecular Medicine at Partners Healthcare, the SHaRe Cardiomyopathy Registry, the NIHR Rare Diseases Translational Research Collaboration) to develop and evaluate new computational methods.

Precision medicine ? we are evaluating the use of genetics and biomarkers to stratify patients and predict their response to therapy and long-term outcomes. Ultimately, we are working to interpret genome information so that it can be used to optimise treatment choice for our patients. We are particularly focusing on genetic stratification of cohorts with hypertrophic and dilated cardiomyopathies. We integrate genetics, biomarkers, and precision phenotyping with electronic medical records and clinical outcome data to identify determinants of prognosis and treatment response.

Titin ? we have a particular focus on the Titin gene, which encodes the largest human protein, a key component of muscles throughout the body. Recently identified as the most important cause of inherited dilated cardiomyopathy, we are working to understand the effects of Titin variants on the heart, their mechanisms of action, and their clinical significance. Our group focuses on computational approaches and statistical genetics in human subjects, and we integrate these data with genomic, transcriptomic, proteomic, and physiological data from model organisms and cellular models through collaboration within and without the MRC Clinical Sciences Centre.

Software ? web resources, software, and other tools developed by the group are available at cardiodb.org</gtr:technicalSummary><gtr:fund><gtr:end>2019-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>139625</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Genomics in Mainstream Medicine Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A38FBAF2-0FB2-4EB2-9440-E9A72945D95E</gtr:id><gtr:impact>Membership of JGenomics in Mainstream Medicine Working Group established by the Joint Committee for Genomics in Medicine (JCGM) of the Royal College of Physicians, the Royal College of Pathologists and British Society for Genetic Medicine in 2013. 
Design of materials and strategy for provision of an genome-literate healthcare workforce</gtr:impact><gtr:outcomeId>58c2a440720959.46735891</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.phgfoundation.org/project/mainstream_medicine/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ClinGen</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D8E30F04-BE92-4587-B857-FFA5F9A1B111</gtr:id><gtr:impact>Participation in the ClinGen (Clinical Genome Resource) Cardiovascular Disease Working group.
Defining standardised workflows and preparing guidelines for the interpretation of genetic variation wrt inherited cardiovascular diseases</gtr:impact><gtr:outcomeId>58c2a55b7c4763.09839442</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>https://www.clinicalgenome.org/working-groups/clinical-domain/sub-groups/cardiovascular/</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>A tool for the interpretation of variation in genes associated with Inherited Cardiac Conditions</gtr:description><gtr:id>21063D72-9A65-4EF0-9AAF-F0CFA36227D4</gtr:id><gtr:impact>Only just launched, so limited impact assessment.
Already received enquiries from diagnostic laboratories and ClinGen interested in using the resource</gtr:impact><gtr:outcomeId>58c2f44ca50f28.43545920</gtr:outcomeId><gtr:title>CardioClassifier</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:url>http://www.cardioclassifier.org</gtr:url><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>A database of cardiac genetic variation, and interpretive portal</gtr:description><gtr:id>EF468820-8C96-4131-8BC1-C8872A3B503B</gtr:id><gtr:impact>Highly accessed resource
Adopted into workflow for variant interpretation internationally</gtr:impact><gtr:outcomeId>58c2f48fc7d8c5.88005119</gtr:outcomeId><gtr:title>ACGV</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:url>http://cardiodb.org/ACGV</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8C869551-6376-496D-8454-47C2CAD2DC74</gtr:id><gtr:title>Utility of Post-Mortem Genetic Testing in Cases of Sudden Arrhythmic Death Syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/033ada50c6749c0503c6058e42511679"><gtr:id>033ada50c6749c0503c6058e42511679</gtr:id><gtr:otherNames>Lahrouchi N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>5aa9cab143f9e6.32165748</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAA390F9-B546-471D-AC15-06E2DA0BAFA5</gtr:id><gtr:title>Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel.</gtr:title><gtr:parentPublicationTitle>Genetics in medicine : official journal of the American College of Medical Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4f08ac89e922f9fa31e1f99767e2d71"><gtr:id>e4f08ac89e922f9fa31e1f99767e2d71</gtr:id><gtr:otherNames>Kelly MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1098-3600</gtr:issn><gtr:outcomeId>5aa9cadf480af7.97876045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>985F6461-2F16-4CD2-A920-0BBF8B054FFC</gtr:id><gtr:title>Titin-truncating variants affect heart function in disease cohorts and the general population.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f8d2d4e72b48fe25b49824d02c0a068"><gtr:id>5f8d2d4e72b48fe25b49824d02c0a068</gtr:id><gtr:otherNames>Schafer S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>587672415afdc7.95481436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C29539A2-499B-4227-B7F6-222CEE28E168</gtr:id><gtr:title>Phenotype and Clinical Outcomes of Titin&amp;nbsp;Cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1190de222c25811b09b21c92dbfd615b"><gtr:id>1190de222c25811b09b21c92dbfd615b</gtr:id><gtr:otherNames>Tayal U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>5aa2c4763ec508.94910779</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8629B275-5816-439E-B51D-A14688AC987B</gtr:id><gtr:title>Using high-resolution variant frequencies to empower clinical genome interpretation.</gtr:title><gtr:parentPublicationTitle>Genetics in medicine : official journal of the American College of Medical Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53b5c93356273ff058389d466ccbc834"><gtr:id>53b5c93356273ff058389d466ccbc834</gtr:id><gtr:otherNames>Whiffin N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1098-3600</gtr:issn><gtr:outcomeId>5aa2c852155ed2.14618437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72F24C8C-0151-4038-83B6-0585E7FBD8E9</gtr:id><gtr:title>Histiocytoid cardiomyopathy and microphthalmia with linear skin defects syndrome: phenotypes linked by truncating variants in.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor molecular case studies</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4699d95a48162893a801bd360c30c248"><gtr:id>4699d95a48162893a801bd360c30c248</gtr:id><gtr:otherNames>Rea G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2373-2873</gtr:issn><gtr:outcomeId>58767241c83c92.48139635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AE5F8BA-2AC7-474A-A95C-412963C43E29</gtr:id><gtr:title>Natural genetic variation of the cardiac transcriptome in non-diseased donors and patients with dilated cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6707be62315faa21f1e03896378178c"><gtr:id>c6707be62315faa21f1e03896378178c</gtr:id><gtr:otherNames>Heinig M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>5aa9cab2085162.70081330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DEB5B64-59C1-423E-9074-EA8C40BDFE56</gtr:id><gtr:title>ClinVar data parsing.</gtr:title><gtr:parentPublicationTitle>Wellcome open research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0d10ae0b5fee7f7d7a790e1b961f1e4"><gtr:id>f0d10ae0b5fee7f7d7a790e1b961f1e4</gtr:id><gtr:otherNames>Zhang X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2398-502X</gtr:issn><gtr:outcomeId>5aa9cab17c7b82.32726381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19159655-EFA7-4CE5-AF0C-6E639BE7B8F6</gtr:id><gtr:title>Truncating Variants in Titin Independently Predict Early Arrhythmias in Patients With Dilated Cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1190de222c25811b09b21c92dbfd615b"><gtr:id>1190de222c25811b09b21c92dbfd615b</gtr:id><gtr:otherNames>Tayal U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>5aa9cab1cf8616.50826681</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0683BBF6-9273-4C5F-BC8A-0106F15CC104</gtr:id><gtr:title>Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da1418e5f15e3c91657abbb6db828597"><gtr:id>da1418e5f15e3c91657abbb6db828597</gtr:id><gtr:otherNames>Walsh R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>58c286e2445d70.73398798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F96BB0D-DEEF-4C3E-AA20-15F796215076</gtr:id><gtr:title>Analysis of protein-coding genetic variation in 60,706 humans.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0502195b3d1a521f69e91ecf1cb5cef6"><gtr:id>0502195b3d1a521f69e91ecf1cb5cef6</gtr:id><gtr:otherNames>Lek M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>587672402bad88.26811623</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3155EB28-D577-41F1-971E-8759AE671DED</gtr:id><gtr:title>Ajmaline blocks Iand Iwithout eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd5b87a08a301672e8ee31a304cc35d6"><gtr:id>fd5b87a08a301672e8ee31a304cc35d6</gtr:id><gtr:otherNames>Miller DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>5aa9cab0bc2521.67490894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54E628FD-FBE7-4762-A73E-DD2EF43DEF26</gtr:id><gtr:title>Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95a1abeef69d7352fe640e6c005437fd"><gtr:id>95a1abeef69d7352fe640e6c005437fd</gtr:id><gtr:otherNames>Alamo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5aa9cab258a660.75474695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AEA3E5D-D875-41C8-8BF6-9B05D71142A9</gtr:id><gtr:title>Titin truncating mutations: A rare cause of dilated cardiomyopathy in the young</gtr:title><gtr:parentPublicationTitle>Progress in Pediatric Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d28c759c60d2adc3e0859e9156b3867f"><gtr:id>d28c759c60d2adc3e0859e9156b3867f</gtr:id><gtr:otherNames>Fatkin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58767241e6be34.99111679</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47500841-CD22-48F2-9F94-FC75DAF114C7</gtr:id><gtr:title>Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83d03b392baf89b91a9860ce401e05f9"><gtr:id>83d03b392baf89b91a9860ce401e05f9</gtr:id><gtr:otherNames>Ware JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>5aa9cab11707c6.32017128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7CD7BEA-C73F-48BA-80D4-B39AA63BEC06</gtr:id><gtr:title>CardioClassifier: disease- and gene-specific computational decision support for clinical genome interpretation.</gtr:title><gtr:parentPublicationTitle>Genetics in medicine : official journal of the American College of Medical Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53b5c93356273ff058389d466ccbc834"><gtr:id>53b5c93356273ff058389d466ccbc834</gtr:id><gtr:otherNames>Whiffin N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1098-3600</gtr:issn><gtr:outcomeId>5aa2c4761cfef8.41796898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8B341BA-9E28-48EA-BAA4-1530D9F4312A</gtr:id><gtr:title>Moderate Physical Activity in Healthy Adults Is Associated With Cardiac Remodeling.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2d1775772530e70b4cfdb213df3b676"><gtr:id>e2d1775772530e70b4cfdb213df3b676</gtr:id><gtr:otherNames>Dawes TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1941-9651</gtr:issn><gtr:outcomeId>587672407566a5.23873328</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50391EBA-DAE7-4366-884A-3CF58ACA59E2</gtr:id><gtr:title>Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.</gtr:title><gtr:parentPublicationTitle>Genetics in medicine : official journal of the American College of Medical Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da1418e5f15e3c91657abbb6db828597"><gtr:id>da1418e5f15e3c91657abbb6db828597</gtr:id><gtr:otherNames>Walsh R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1098-3600</gtr:issn><gtr:outcomeId>58767241786e43.33880531</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26BBFBB1-C092-484E-A5C7-9CF3BF8A7F81</gtr:id><gtr:title>Role of titin in cardiomyopathy: from DNA variants to patient stratification.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83d03b392baf89b91a9860ce401e05f9"><gtr:id>83d03b392baf89b91a9860ce401e05f9</gtr:id><gtr:otherNames>Ware JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1759-5002</gtr:issn><gtr:outcomeId>5aa9cab22f54d2.03777249</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A71F912C-AFAA-456A-A5F3-5ABB92A46DE2</gtr:id><gtr:title>Recovery of Cardiac Function in Cardiomyopathy Caused by Titin Truncation.</gtr:title><gtr:parentPublicationTitle>JAMA cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b52c027f944395e859c7fe9341d215d"><gtr:id>6b52c027f944395e859c7fe9341d215d</gtr:id><gtr:otherNames>Felkin LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>587672413c61b3.96625512</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_1102/20</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>